Skip to main content
Fig. 2 | Applied Cancer Research

Fig. 2

From: IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients

Fig. 2

IL32 expression and IL32 transcript variants in myelodysplastic syndromes. qPCR analysis of total IL32 a, IL32α b, IL32β c, IL32γ d and IL32δ e mRNA levels in CD3+ cells from healthy donors and from patients with the diagnosis of myelodysplastic syndromes (MDS). MDS patients were stratified using the WHO 2008 classification intro refractory anemia (RA)/refractory anemia with ringed sideroblasts (RARS)/refractory cytopenia with multilineage dysplasia (RCMD) groups and refractory anemia with excess blast-1 (RAEB-1)/refractory anemia with excess blast-2 (RAEB-2) groups. The “y” axis represents the relative gene mRNA expression. The numbers of subjects studied are indicated in the graph

Back to article page
\